Iwao, K., Kawasaki, H., Taira, K., and Yokoyama, K. K. (1999). Ubiquitination of the transcriptional coactivator p300 during retinic acid induced differentiation. Nucleic Acids Symp Ser, 207-208.

Jaboin, J., Wild, J., Hamidi, H., Khanna, C., Kim, C. J., Robey, R„ Bates, S. E„ and Thiele, C. J. (2002). MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res 62, 6108-6115.

Jenuwein, T., and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-1080.

Jiang, H., Nucifora, F. C., Jr., Ross, C. A., and DeFranco, D. B. (2003). Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum Mol Genet 12, 1-12. John, S., Howe, L., Tafrov, S. T., Grant, P. A., Sternglanz, R., and Workman, J. L. (2000). The something about silencing protein, Sas3, is the catalytic subunit of NuA3, a yTAF(II)30-containing HAT complex that interacts with the Sptl6 subunit of the yeast CP (Cdc68/Pob3)-FACT complex. Genes Dev 14, 1196-1208. Kadosh, D., and Struhl, K. (1998). Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo. Mol Cell Biol 18, 5121-5127.

Kaeberlein, M., McVey, M., and Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13, 2570-2580.

Kalkhoven, E. (2004). CBP and p300: HATs for different occasions. Biochem Pharmacol 68, 1145-1155. Kamine, J., Elangovan, B., Subramanian, T., Coleman, D., and Chinnadurai, G. (1996). Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology 216, 357-366. Kang-Decker, N., Tong, C., Boussouar, F., Baker, D. J., Xu, W., Leontovich, A. A., Taylor, W. R., Brindle, P. K., and van Deursen, J. M. (2004). Loss of CBP causes T cell lymphomagenesis in synergy with p27Kipl insufficiency. Cancer Cell J, 177-189. Kao, G. D., McKenna, W. G., Guenther, M. G., Muschel, R. J., Lazar, M. A., and Yen, T. J. (2003). Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response. J Cell Biol 160, 1017-1027.

Katan-Khaykovich, Y., and Struhl, K. (2002). Dynamics of global histone acetylation and deacetylation in vivo: rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev 16, 743-752.

Kawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., and Yao, T. P. (2003). The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115, 727-738.

Kawasaki, H., Schiltz, L., Chiu, R., Itakura, K., Taira, K.,

Nakatani, Y., and Yokoyama, K. K. (2000). ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature 405, 195-200.

Kehle, J., Beuchle, D., Treuheit, S., Christen, B., Kennison, J. A., Bienz, M., and Muller, J. (1998). dMi-2, a hunchback-interacting protein that functions in polycomb repression. Science 282, 1897-1900.

Kelly, W. K„ Richon, V. M., O'Connor, 0., Curley, T„ MacGregor-Curtelli, B., Tong, W., Klang, M., Schwartz, L., Richardson, S., Rosa, E„ et al. (2003). Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin Cancer Res 9, 3578-3588. Kikuchi, H., Takami, Y„ and Nakayama, T. (2005). GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes. Gene.

Kim, M. S., Son, M. W„ Kim, W. B., In Park, Y„ and Moon, A. (2000a). Apicidin, an inhibitor of histone deacetylase, prevents H-ras-induced invasive phenotype. Cancer Lett 157, 23-30. Kim, Y. B„ Ki, S. W„ Yoshida, M., and Horinouchi, S. (2000b). Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells. J Antibiot (Tokyo) 53, 1191-1200.

Kimura, A., Umehara, T., and Horikoshi, M. (2002). Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing. Nat Genet 32, 370-377.

Kleff, S., Andrulis, E. D., Anderson, C. W., and Sternglanz, R.

(1995). Identification of a gene encoding a yeast histone H4

acetyltransferase. J Biol Chem 270, 24674-24677.

Koipally, J., Renold, A., Kim, J., and Georgopoulos, K. (1999).

Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. Embo J 18, 3090-3100.

Kouzarides, T. (2000). Acetylation: a regulatory modification to rival phosphorylation? Embo J 19, 1176-1179.

Kundu, T. K„ Wang, Z„ and Roeder, R. G. (1999). Human

TFIIIC relieves chromatin-mediated repression of RNA

polymerase III transcription and contains an intrinsic histone acetyltransferase activity. Mol Cell Biol 19, 1605-1615.

Kung, A. L„ Rebel, V. I., Bronson, R. T., Ch'ng, L. E„ Sieff, C.

A., Livingston, D. M., and Yao, T. P. (2000). Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by

CBP. Genes Dev 14, 272-277.

Kuo, M. H., Zhou, J., Jambeck, P., Churchill, M. E., and Allis, C. D. (1998). Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev 12, 627-639.

Kurdistani, S. K., and Grunstein, M. (2003). Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 4, 276-284. Kusch, T., Florens, L., Macdonald, W. H., Swanson, S. K., Glaser, R. L., Yates, J. R., 3rd, Abmayr, S. M., Washburn, M. P., and Workman, J. L. (2004). Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 306, 2084-2087.

L'Hernault, S. W., and Rosenbaum, J. L. (1985). Chlamydomonas alpha-tubulin is posttranslationally modified by acetylation on the epsilon-amino group of a lysine. Biochemistry 24, 473-478.

Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., and Jenuwein,

T. (2001). Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 116-120.

Lang, S. E., and Hearing, P. (2003). The adenovirus E1A

oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene 22, 2836-2841.

Lang, S. E., McMahon, S. B., Cole, M. D., and Hearing, P.

(2001). E2F transcriptional activation requires TRRAP and

GCN5 cofactors. J Biol Chem 276, 32627-32634.

Lavau, C„ Du, C., Thirman, M„ and Zeleznik-Le, N. (2000).

Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia. Embo J 19, 4655-4664.

Lee, H. J., Chun, M., and Kandror, K. V. (2001). Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling. J Biol Chem 276, 16597-16600.

Lemercier, C., Brocard, M. P., Puvion-Dutilleul, F., Kao, H. Y.,

Albagli, O., and Khochbin, S. (2002). Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor. J Biol Chem 277, 22045-22052.

Linseman, D. A., Bartley, C. M., Le, S. S., Laessig, T. A.,

Bouchard, R. J., Meintzer, M. K., Li, M., and Heidenreich, K. A.

(2003). Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-

dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J Biol Chem 2 78, 41472-41481.

Liu, F., Dowling, M., Yang, X. J., and Kao, G. D. (2004).

Caspase-mediated specific cleavage of human histone deacetylase 4. J Biol Chem 279, 34537-34546.

Lonard, D. M., Nawaz, Z., Smith, C. L., and O'Malley, B. W.

(2000). The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol Cell 5, 939-948.

Lu, J., McKinsey, T. A., Zhang, C. L., and Olson, E. N. (2000).

Regulation of skeletal myogenesis by association of the MEF2

transcription factor with class II histone deacetylases. Mol Cell 6,

0 0

Post a comment